findmyKOL
Clinical trialNCT01191450CompletedPhase 3Interventional

Safety and Efficacy of Chlorthalidone + Amiloride to Elderly Patients Treatment With Arterial Hypertension

SponsorEurofarma Laboratorios S.A.Enrollment246Arterial Hypertension
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to assess the efficacy and safety of Chlorthalidone 25 mg + amiloride hydrochloride 5 mg association in the treatment of elderly patients with arterial hypertension.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Adriana C Forti

    Centro de Estudos de Diabetes e Hipertensão

    Principal Investigator
    clinicaltrials.gov ↗
  • Daniela G Barbieri

    CEDOES - Centro de Diagnóstico e Pesquisa de Osteoporose do Espírito Santo

    Principal Investigator
    clinicaltrials.gov ↗
  • Fernando Augusto A Costa

    FGM - Clínica Paulista de Doenças Cardiovasculares

    Principal Investigator
    clinicaltrials.gov ↗
  • Fábio José C Fucci

    Instituto de Moléstias Cardiovasculares de Tatuí

    Principal Investigator
    clinicaltrials.gov ↗
  • Humberto Freitas

    Hospital São Camilo

    Principal Investigator
    clinicaltrials.gov ↗
  • Jose Carlos A Ayob

    Centro de Pesquisas Clínicas do Instituto de Moléstias Cardiovasculares

    Principal Investigator
    clinicaltrials.gov ↗
  • Marise L Castro

    IMA - Instituto de Medicina Avançada

    Principal Investigator
    clinicaltrials.gov ↗
  • Paulo Cesar V Jardim

    Liga de Hipertensão Arterial - Universidade Federal de Goiás

    Principal Investigator
    clinicaltrials.gov ↗
  • Paulo Guilherme O Silva

    Hospital Santa Marcelina

    Principal Investigator
    clinicaltrials.gov ↗
  • Roberto Jorge S Franco

    Unidade de Pesquisa Clínica (UPECLIN)- Hospital das Clínicas UNESP

    Principal Investigator
    clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Brazil
  • Centro de Estudos de Diabetes E Hipertensão

    Fortaleza, Ceará, Brazil

  • Cedoes - Centro de Diagnóstico E Pesquisa de Osteoporose Do Espírito Santo

    Vitória, Espírito Santo, Brazil

  • Liga de Hipertensão Arterial - Universidade Federal de Goiás

    Goiânia, Goiás, Brazil

  • Upeclin - Unidade de Pesquisa Clínica Da Faculdade de Medicina - Unesp

    Botucatu, São Paulo, Brazil

  • Centro de Pesquisa Clínica Do Imc - Instituto de Moléstias Cardiovasculares

    São José do Rio Preto, São Paulo, Brazil

  • Instituto de Moléstias Cardiovasculares de Tatuí

    Tatuí, São Paulo, Brazil

  • Clínica Paulista de Doenças Cardiovasculares - Fgm

    São Paulo, Brazil

  • Hospital Santa Marcelina

    São Paulo, Brazil

  • Hospital São Camilo

    São Paulo, Brazil

  • Ima - Instituto de Medicina Avançada

    São Paulo, Brazil

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Chlorthalidone →Higroton® Laboratório Novartis
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Aug 2011
Primary completion
31 Aug 2013
Completion
31 Aug 2013
Last update posted
12 Jun 2025
Registered enrollment
246
Registry id
NCT01191450
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.